Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03702673 · ClinicalTrials.gov registry record · Phase 1
Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.
A Phase 1 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT03702673 is a Phase 1 study that has completed, run by Kowa Research Institute. The registered enrollment target is 12 participants.
The verdict
NCT03702673, a Phase 1 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
A study to compare the pharmacokinetics of 3 types of K-877 controlled release tablets with a current normal K-877 tablet in healthy adult subjects.
Interventions
- DRUG K-877 CR Tablet A
- DRUG K-877 CR Tablet B
- DRUG K-877 CR Tablet E
- DRUG K-877 IR Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-10-05 |
| Est. Completion | 2018-11-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03702673
The ClinicalTrials.gov registry entry for NCT03702673 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which K-877 CR Tablet A is the first listed.
NCT03702673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03702673 about?
NCT03702673 is a clinical study titled "Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.". A study to compare the pharmacokinetics of 3 types of K-877 controlled release tablets with a current normal K-877 tablet in healthy adult subjects.
What is the current status of trial NCT03702673?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2018-10-05. Estimated completion is 2018-11-20.
What interventions are being tested in trial NCT03702673?
The interventions under investigation include: K-877 CR Tablet A (DRUG), K-877 CR Tablet B (DRUG), K-877 CR Tablet E (DRUG), K-877 IR Tablet (DRUG).
Who is sponsoring clinical trial NCT03702673?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.